S100 Risk of cardiovascular morbidity and mortality in people with chronic obstructive pulmonary disease versus those without COPD: A structured review of the evidence

Abstract

of a novel fibre-based FLIM which utilises 488nm excitation to enable fluorescence intensity and lifetime imaging, to detect changes in freshly resected lung cancer and adjacent healthy tissue. The mechanisms responsible for altera-tions in lung cancer fluorescence lifetime are not understood. We investigate the contributions of cancer cells and tumour stroma to fluorescence lifetime signatures using fixed unstained lung cancer and benchtop FLIM. different timepoints, between 2 hours and 1 year from presentation. in the instruments used to evaluate treatment or failure in COPD exacerbation trials. Standardization could promote comparability.